Safety Study of AMG 557 in Subjects With Lupus Arthritis
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, parallel, placebo-controlled, multiple dose
study that will enroll approximately 40 systemic lupus erythematosus subjects with active
lupus arthritis.